CAS 1847485-91-9

Ilorasertib hydrochloride

CAS : 1847485-91-9

Formule : C₂₅H₂₂ClFN₆O₂S

Degré de pureté : 98%

Masse moléculaire : 524.9976

Ref: IN-DA01V3M2

Ilorasertib hydrochloride

CAS : 1847485-91-9

Ilorasertib hydrochloride

Degré de pureté : ≥98%

Masse moléculaire : 525g/mol

Ref: 54-BUP21821

Ilorasertib hydrochloride

CAS : 1847485-91-9

Ilorasertib hydrochloride is a selective multi-targeted kinase inhibitor, which is derived from meticulous synthetic chemistry processes aimed at producing potent therapeutic agents. With a primary mechanism of action that involves the inhibition of several key kinases, Ilorasertib hydrochloride acts to disrupt critical signaling pathways essential for cancer cell proliferation and survival. This mechanistic approach involves the targeting of enzymes such as cyclin-dependent kinases (CDKs) and VEGFR, which are pivotal in various cancerous processes.

Formule : C₂₅H₂₂ClFN₆O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 525 g/mol

Ref: 3D-XYC48591

Ilorasertib hydrochloride

CAS : 1847485-91-9

Ilorasertib hydrochloride (ABT-348 hydrochloride) is an ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A (IC50s:

Formule : C₂₅H₂₂ClFN₆O₂S

Degré de pureté : 98.45%

Couleur et forme : Solid

Masse moléculaire : 525

Ref: TM-T11638